Skip to main content

Advertisement

Log in

Reduced Attention in Former Smokers with and without COPD

  • Full length manuscript
  • Published:
International Journal of Behavioral Medicine Aims and scope Submit manuscript

Abstract

Background

Attention difficulties are often reported by patients with chronic obstructive pulmonary disease (COPD); however, limited research exists using objective tests designed specifically to measure attention in this population. This study aimed to (1) identify specific attention deficits in COPD and (2) determine which demographic/clinical characteristics are associated with reduced attention.

Methods

Eighty-four former smokers (53 COPD, 31 no COPD) completed questionnaires, pulmonary function testing, and the Conner’s Continuous Performance Test II (CPT-II). Participants with and without COPD were compared on CPT-II measures of inattention, impulsivity, and vigilance. CPT-II measures that differed significantly between the two groups were further examined using hierarchical regression modeling. Demographic/clinical characteristics were entered into models with attention as the dependent variable.

Results

Participants with COPD performed worse than those without COPD on CPT measures of inattention and impulsivity (i.e., detectability [discrimination of target from non-target stimuli], perseverations [reaction time under 100 ms], omissions [target stimuli response failures], and commissions [responses to non-target stimuli]). More severe COPD (measured by greater airflow limitation) was associated with poorer ability to detect targets vs. foils and perseverative responding after adjusting for age and other covariates in the model.

Conclusion

Former smokers with COPD experience problems with attention that go beyond slowed processing speed, including aspects of inattention and impulsivity. Clinicians should be aware that greater airflow limitation and older age are associated with attention difficulties, as this may impact functioning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71(5):581–8. https://doi.org/10.1001/jamaneurol.2014.94.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Global Initiative for Chronic Obstructive Lung Disease. (2019). Retrieved from http://www.goldcopd.org.

  3. Shrikrishna D, Hopkinson NS. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin Med (Lond). 2012;12(1):71–4.

    Article  Google Scholar 

  4. Kozora E, Tran ZV, Make B. Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardpulm Rehabil. 2002;22(6):426–30.

    Article  Google Scholar 

  5. Torres-Sanchez I, Rodriguez-Alzueta E, Cabrera-Martos I, Lopez-Torres I, Moreno-Ramirez MP, Valenza MC. Cognitive impairment in COPD: a systematic review. J Bras Pneumol. 2015;41(2):182–90. https://doi.org/10.1590/S1806-37132015000004424.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med. 2007;37(1):97–107. https://doi.org/10.1017/S0033291706008713.

    Article  PubMed  Google Scholar 

  7. Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S. A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS One. 2012;7(2):e31500. https://doi.org/10.1371/journal.pone.0031500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10:99. https://doi.org/10.1186/1741-7015-10-99.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sobanski E, Bruggemann D, Alm B, et al. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2007;257(7):371–7. https://doi.org/10.1007/s00406-007-0712-8.

    Article  PubMed  Google Scholar 

  10. Surman CB, Biederman J, Spencer T, Miller CA, McDermott KM, Faraone SV. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. Atten Defic Hyperact Disord. 2013;5(3):273–81. https://doi.org/10.1007/s12402-012-0100-8.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Humfleet GL, Prochaska JJ, Mengis M, Cullen J, Muñoz R, Reus V, et al. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res. 2005;7(3):453–60. https://doi.org/10.1080/14622200500125310.

    Article  PubMed  Google Scholar 

  12. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abus. 1995;7(3):373–8.

    Article  CAS  Google Scholar 

  13. Charbonnier JP, Pompe E, Moore C, Humphries S, van Ginneken B, Make B, et al. Airway wall thickening on CT: relation to smoking status and severity of COPD. Respir Med. 2019;146:36–41. https://doi.org/10.1016/j.rmed.2018.11.014.

    Article  PubMed  Google Scholar 

  14. Alosco ML, Spitznagel MB, Josephson R, Hughes J, Gunstad J. COPD is associated with cognitive dysfunction and poor physical fitness in heart failure. Heart Lung. 2015;44(1):21–6. https://doi.org/10.1016/j.hrtlng.2014.09.002.

    Article  PubMed  Google Scholar 

  15. Dodd JW, Novotny P, Sciurba FC, Benzo RP, Group NR. Executive function, survival, and hospitalization in chronic obstructive pulmonary disease. A longitudinal analysis of the National Emphysema Treatment Trial (NETT). Ann Am Thorac Soc. 2015;12(10):1473–81. https://doi.org/10.1513/AnnalsATS.201506-373OC.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998;17(3):232–40.

    Article  CAS  PubMed  Google Scholar 

  17. Feng L, Lim ML, Collinson S, Ng TP. Pulmonary function and cognitive decline in an older Chinese population in Singapore. COPD. 2012;9(5):555–62. https://doi.org/10.3109/15412555.2012.706341.

    Article  PubMed  Google Scholar 

  18. Ryu CW, Jahng GH, Choi CW, Rhee HY, Kim MJ, Kim SM, et al. Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRI. COPD. 2013;10(3):357–66. https://doi.org/10.3109/15412555.2012.752808.

    Article  PubMed  Google Scholar 

  19. Tulek B, Atalay NB, Yildirim G, Kanat F, Suerdem M. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Respirology. 2014;19(6):873–80. https://doi.org/10.1111/resp.12333.

    Article  PubMed  Google Scholar 

  20. Klein M, Gauggel S, Sachs G, Pohl W. Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respir Med. 2010;104(1):52–60. https://doi.org/10.1016/j.rmed.2009.08.008.

    Article  CAS  PubMed  Google Scholar 

  21. Castaneda AE, Marttunen M, Suvisaari J, Perälä J, Saarni SI, Aalto-Setälä T, et al. The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults. Psychol Med. 2010;40(1):29–39. https://doi.org/10.1017/S0033291709005959.

    Article  CAS  PubMed  Google Scholar 

  22. Del Brutto OH, Mera RM, Del Brutto VJ, et al. Influence of depression, anxiety and stress on cognitive performance in community-dwelling older adults living in rural Ecuador: results of the Atahualpa project. Geriatr Gerontol Int. 2015;15(4):508–14. https://doi.org/10.1111/ggi.12305.

    Article  PubMed  Google Scholar 

  23. Ng J, Chan HY, Schlaghecken F. Dissociating effects of subclinical anxiety and depression on cognitive control. Adv Cogn Psychol. 2012;8(1):38–49. https://doi.org/10.2478/v10053-008-0100-6.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Weiland-Fiedler P, Erickson K, Waldeck T, Luckenbaugh DA, Pike D, Bonne O, et al. Evidence for continuing neuropsychological impairments in depression. J Affect Disord. 2004;82(2):253–8. https://doi.org/10.1016/j.jad.2003.10.009.

    Article  PubMed  Google Scholar 

  25. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43. https://doi.org/10.3109/15412550903499522.

    Article  PubMed  Google Scholar 

  26. Conners CK. CPT II Technical Guide and Software Manual. Toronto, ON: Multi Health Systems Incorporated; 2000.

    Google Scholar 

  27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  CAS  PubMed  Google Scholar 

  28. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):841–6. https://doi.org/10.1053/rmed.2000.0804.

    Article  CAS  PubMed  Google Scholar 

  29. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax. 1996;51(1):44–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Sutton K, Cooper M, Pimm J, Wallace L. Anxiety in chronic obstructive pulmonary disease: the role of illness specific catastrophic thoughts. Cogn Ther Res. 1999;23:573–85. https://doi.org/10.1023/A:1018780623406.

    Article  Google Scholar 

  31. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38. https://doi.org/10.1183/09031936.05.00034805.

    Article  CAS  PubMed  Google Scholar 

  32. Verstraeten E, Cluydts R, Pevernagie D, Hoffman G. Executive function in sleep apnea: controlling for attentional capacity and assessing executive attention. Sleep. 2004;27(4):685–93.

    PubMed  Google Scholar 

  33. Tulek B, Atalay NB, Kanat F, Suerdem M. Attetnional control is partially impaired in obstructive sleep apnea syndrome. J Sleep Res. 2013;22(4):422–9. https://doi.org/10.1111/jsr.12038.

    Article  PubMed  Google Scholar 

  34. Mani TM, Bedwell JS, Miller LS. Age-related decrements in performance on a brief continuous performance test. Arch Clin Neuropsychol. 2005;20:575–86. https://doi.org/10.1016/j.acn2004.12.008.

    Article  PubMed  Google Scholar 

  35. Goodwin RD, Lewinsohn PM, Seeley JR. Respiratory symptoms and mental disorders among youth: results from a prospective, longitudinal study. Psychosom Med. 2004;66(6):943–9. https://doi.org/10.1097/01.psy.0000138123.70740.92.

    Article  PubMed  Google Scholar 

  36. Holmberg K, Lundholm C, Anckarsater H, Larsson H, Almqvist C. Impact of asthma medication and familial factors on the association between childhood asthma and attention-deficit/hyperactivity disorder: a combined twin- and register-based study: epidemiology of allergic disease. Clin Exp Allergy. 2015;45(5):964–73. https://doi.org/10.1111/cea.12529.

    Article  CAS  PubMed  Google Scholar 

  37. Kwon HJ, Lee MY, Ha M, Yoo SJ, Paik KC, Lim JH, et al. The associations between ADHD and asthma in Korean children. BMC Psychiatry. 2014;14:70. https://doi.org/10.1186/1471-244X-14-70.

    Article  PubMed  PubMed Central  Google Scholar 

  38. McQuaid EL, Weiss-Laxer N, Kopel SJ, Mitchell DK, Nassau JH, Wamboldt MZ, et al. Pediatric asthma and problems in attention, concentration, and impulsivity: disruption of the family management system. Fam Syst Health. 2008;26(1):16–29. https://doi.org/10.1037/1091-7527.26.1.16.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Yuksel H, Sogut A, Yilmaz O. Attention deficit and hyperactivity symptoms in children with asthma. J Asthma. 2008;45(7):545–7. https://doi.org/10.1080/02770900801990016.

    Article  PubMed  Google Scholar 

  40. Stollings JL, Wilson JE, Jackson JC, Wesley EE. Executive dysfunction following critical illness: exploring risk factors and management options in geriatric populations. Curr Behav Neurosci Rep. 2016;3:176–84.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Szuromi B, Bitter I, Czobor P. Functional impairment in adults positively screened for attention-deficit hyperactivity disorder: the role of symptom presentation and executive functioning. Compr Psychiatry. 2013;54(7):974–81. https://doi.org/10.1016/j.comppsych.2013.04.002.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karin F. Hoth.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Croghan, A., Brunette, A., Holm, K.E. et al. Reduced Attention in Former Smokers with and without COPD. Int.J. Behav. Med. 26, 600–607 (2019). https://doi.org/10.1007/s12529-019-09826-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12529-019-09826-y

Keywords

Navigation